Optimer Pharmaceuticals, Inc. · San Diego, CA United States (NASDAQ: OPTR)
| 10110 Sorrento Valley Rd., Ste. C | Phone: 858-909-0736 |
| San Diego, CA | Fax: 858-909-0737 |
| 92121 | |
| United States | 
Map This Company |
Optimer Pharmaceuticals, Inc. Rankings
| Russell 2000 (June 2011) |
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Optimer Pharmaceuticals has good reason to be optimistic: its lead drug Fidaxomicin kills a wicked and persistent bacteria better than anything else. Presented under the market name Dificid, Fidaxomicin has been approved for treating Clostridium difficile-associated diarrhea, commonly acquired in hospitals. Its Pruvel antibiotic is also in late-stage clinical trials for the treatment of infectious traveler's diarrhea. Through the manipulation of carbohydrates, the company is using its OPopS technology to identify other potential drug candidates for diseases such as breast cancer and respiratory tract infections.
Optimer Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: OPTR Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 278 |
Executives
29 executives listed for Optimer Pharmaceuticals, Inc.'s San Diego, CA location.
| President, CEO, and Director | S. Pedro Lichtinger | |
|---|---|---|
| SVP Corporate Affairs and COO | Tessie Che | |
| VP Finance, CFO, and Corporate Secretary | John Prunty |